|
|
|
|
Noven Pharmaceuticals, Inc. - Financial and Strategic Analysis Review - New Company and Market Analysis
www.companiesandmarkets.com/Summary-Company-Profile/noven-pharma ..Noven Pharmaceuticals, Inc. - Financial and Strategic Analysis Review Summary Noven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company focused on the...
|
|
|
MedWatch - Stimulant Medication in Children with AD/HD - FDA Perspective on Study Data Published about Potenti
Products involved include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse (lisdexamfetamine dimesylate); Desoxyn (methamphetamine);...
|
|
|
FDA comments on ongoing safety review of stimulant medications in children with ADHD
Products involved include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse (lisdexamfetamine dimesylate); Desoxyn (methamphetamine);...
|
|
|
Children who get ADHD drugs score higher on tests
A study that tracked 594 children diagnosed with ADHD from kindergarten through fifth grade found the 60 per cent who were prescribed drugs such as Ritalin and Adderall performed better on standardized tests than peers with ADHD who were not...
|
|
|
Noven Announces 2009 First Quarter Financial Results
- (NewsRx.com) -- Noven Pharmaceuticals, Inc.(NASDAQ:NOVN) announced financial results for the quarter ended March 31, 2009 (the 2009 Quarter), reporting diluted earnings per share of $0.18 for the 2009 Quarter versus diluted earnings per...
|
|
|
Noven Pharmaceuticals shares rise as Jefferies analyst upgrades stock on sales potential
NEW YORK (AP) - Shares of Noven Pharmaceuticals Inc.gained ground Tuesday after a Jefferies & Co. analyst upgraded his rating on the stock, citing the growth potential for its estrogen and ADHD products. The stock rose 50 cents,...
|
|
|
Noven Announces 2009 First Quarter Financial Results
Improved Gross Margin Contributes to 73% Increase in Net Income Noven Raising Earnings Per Share Guidance for Full Year 2009 CEO Comment As our financial results and business highlights suggest, Noven is off to a strong start in 2009, with...
|
